Stephen Colella, a disability reviewer from UMass Medical School, has been honored by the New England Patriots Charitable Foundation for creating and managing a job search initiative.
UMass Medical School experts will present how Medicaid expansion affects the way medical frailty is defined in states, and the positive impact of patient-centered care on children enrolled in the Massachusetts Medicaid program, at the AcademyHealth Annual Research Meeting June 25-27 in New Orleans, Louisiana.
Roughly one-sixth of the country lives in states that are likely to seek waivers under the American Health Care Act (AHCA), which could dramatically revamp the individual, or non-group, health insurance market, said UMass Medical School expert Terry Dougherty, MPH.
A keynote on language access in healthcare settings, the third annual presentation of the Tony Winsor Award and workshops on the opioid crisis and the interpreter role in neuropsychological testing will be featured at the 12th annual Paving the Way to Health Care Access Conference sponsored by UMass Medical School and MassHealth, the Massachusetts Medicaid program.
States across the country will face agonizing choices over who gets health coverage and who doesn’t if proposed deep cuts to Medicaid clear Congress, notes Terry Dougherty, MPH, executive director of Health Systems Transformation at UMass Medical School.
UMass Medical School's Joyce A. Murphy, MPA, executive vice chancellor of the Commonwealth Medicine division, recently had the honor of being elected to the position of chair of the board of Harvard Pilgrim Health Care.
The cloud over the future of the Affordable Care Act (ACA) is proving to be a major threat to the stability of the health insurance exchanges that are the backbone of the law, says UMass Medical School’s Robert W. Seifert, MPA.
Despite the American Health Care Act (AHCA) passing the House, there seems no clear pathway to repealing and replacing the Affordable Care Act (ACA). An alternative to federal legislation is the state waiver process, already in place. In an effort to assist states seeking to waive provisions of the ACA, the U.S. Department of Health & Human Services on May 16 announced a checklist.
As the Senate debate of the American Health Care Act (AHCA) heats up in Washington, D.C, legislators, health care leaders and the American public are calling for a serious discussion on moving to a single-payer health system.
States could wind up dealing with “massive” damage if there are deep cuts in federal health funding that helps pay for opioid addiction treatment, UMass Medical School’s Tyson Thompson, PharmD, tells Managed Healthcare Executive. Thompson and Kimberly Lenz, PharmD, clinical pharmacy manager in UMass Medical School's Office of Clinical Affairs, discussed the most pressing issues surrounding opioid use and misuse with Managed Healthcare Executive for the story, “14 things Trump needs to know about opioids.”
There is growing awareness that if you want your wishes followed for the medical care you are given – or not given – at the end of your life, you should talk about it in advance with your loved ones and doctor, says a new report co-authored by UMass Medical School for the Massachusetts Coalition of Serious Illness Care.
Even as the repeal of Obamacare looms, it is likely to be politically challenging for states to completely jettison a centerpiece of the Affordable Care Act (ACA) that has extended health insurance to millions across the country, says UMass Medical School’s Robert W. Seifert, MPA.
There may be grounds yet for some key bipartisan cooperation on health care reform even amid the fierce debate in Washington, DC over the hot button issue, says UMass Medical School health policy expert Robert W. Seifert, MPA.
The Affordable Care Act (ACA) was designed like a puzzle with each provision necessary for the law to take shape and succeed, which is why it has been difficult for Congress to repeal the landmark 2010 health insurance reform law, says UMass Medical School’s Robert Seifert, MPA.
InterveneRx is launching its InterV CM+ platform with Allied National, Inc. in a first of its kind care management program for specialty drug patients that integrates evidenced based protocols with biometric devices and a mobile application for real-time clinical monitoring. Over 50 patients across 19 states will be monitored for improvements in clinical outcomes, utilization and patient engagement. UMass Medical School is providing a clinically enhanced specialty drug prior authorization process.